Panel Discussion: Evaluating the Need for Biomarker & Patient Selection Tools in an Increasingly Busy ADC Field: What are the Predictions for Future ADC Precision Medicine Approaches?
Time: 4:00 pm
day: Conference Day Two pt 2
Details:
• What is the current need and appetite for ADC biomarker development and patient selection strategies heading into 2025?
• Discussing the different methodologies across machine learning and digital pathology to quantify IHC derived ADC target expression
• Addressing the challenges and opportunities of biomarker analysis to select patient populations to benefit from specific ADCs
• Summarising future predictions for precision medicine ADC development
